Frontiers in Immunology (Dec 2022)
Delineating the molecular landscape of different histopathological growth patterns in colorectal cancer liver metastases
- Mingtao Hu,
- Mingtao Hu,
- Zhigang Chen,
- Zhigang Chen,
- Dandan Hu,
- Dandan Hu,
- Shaoyan Xi,
- Shaoyan Xi,
- Deshen Wang,
- Deshen Wang,
- Xiaolong Zhang,
- William Pat Fong,
- William Pat Fong,
- Lei Wen,
- Lei Wen,
- Yanyu Cai,
- Yanyu Cai,
- Yunfei Yuan,
- Yunfei Yuan,
- Binkui Li,
- Binkui Li,
- Xiaojun Wu,
- Xiaojun Wu,
- Zhenhai Lu,
- Zhenhai Lu,
- Gong Chen,
- Gong Chen,
- Liren Li,
- Liren Li,
- Peirong Ding,
- Peirong Ding,
- Zhizhong Pan,
- Zhizhong Pan,
- Desen Wan,
- Desen Wan,
- Ziming Du,
- Ziming Du,
- Minshan Chen,
- Minshan Chen,
- Yuhong Li,
- Yuhong Li
Affiliations
- Mingtao Hu
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Mingtao Hu
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Zhigang Chen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Zhigang Chen
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Dandan Hu
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Dandan Hu
- Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Shaoyan Xi
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Shaoyan Xi
- Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Deshen Wang
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Deshen Wang
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Xiaolong Zhang
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- William Pat Fong
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- William Pat Fong
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Lei Wen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Lei Wen
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Yanyu Cai
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Yanyu Cai
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Yunfei Yuan
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Yunfei Yuan
- Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Binkui Li
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Binkui Li
- Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Xiaojun Wu
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Xiaojun Wu
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Zhenhai Lu
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Zhenhai Lu
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Gong Chen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Gong Chen
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Liren Li
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Liren Li
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Peirong Ding
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Peirong Ding
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Zhizhong Pan
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Zhizhong Pan
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Desen Wan
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Desen Wan
- Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Ziming Du
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Ziming Du
- Department of Molecular Diagnostics, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Minshan Chen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Minshan Chen
- Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Yuhong Li
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China
- Yuhong Li
- Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
- DOI
- https://doi.org/10.3389/fimmu.2022.1045329
- Journal volume & issue
-
Vol. 13
Abstract
BackgroundHistopathological growth patterns (HGPs) have shown important prognostic values for patients with colorectal cancer liver metastases, but the potential molecular mechanisms remain largely unknown.MethodsWe performed an exploratory analysis by conducting the RNA sequencing of primary colorectal lesions, colorectal liver metastatic lesions and normal liver tissues.FindingsWe found that desmoplastic HGPs of the metastatic lesions were significantly enriched in EMT, angiogenesis, stroma, and immune signaling pathways, while replacement HGPs were enriched in metabolism, cell cycle, and DNA damage repair pathways. With the exception of immune-related genes, the differentially expressed genes of the two HGPs from colorectal liver metastases were mostly inherited from the primary tumor. Moreover, normal liver tissue in the desmoplastic HGP subgroup was markedly enriched in the fibrinous inflammation pathway.ConclusionsWe surmised that HGPs are observable morphological changes resulting from the regulation of molecular expressions, which is the combined effect of the heterogeneity and remodeling of primary tumors seeds and liver soils.
Keywords
- colorectal cancer liver metastases
- histopathological growth pattern
- RNA sequencing
- tumor microenvironment
- soil and seeds